These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 36295042)

  • 1. Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic Options.
    Pelle MC; Zaffina I; Lucà S; Forte V; Trapanese V; Melina M; Giofrè F; Arturi F
    Life (Basel); 2022 Oct; 12(10):. PubMed ID: 36295042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
    Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
    mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction.
    Amraei R; Rahimi N
    Cells; 2020 Jul; 9(7):. PubMed ID: 32660065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury.
    Rossouw TM; Anderson R; Manga P; Feldman C
    Front Immunol; 2022; 13():776861. PubMed ID: 35185878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal Manifestations of Covid-19: Physiology and Pathophysiology.
    Armaly Z; Kinaneh S; Skorecki K
    J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33804075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients.
    Kumar A; Narayan RK; Kumari C; Faiq MA; Kulandhasamy M; Kant K; Pareek V
    Med Hypotheses; 2020 Dec; 145():110320. PubMed ID: 33032170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.
    Ni W; Yang X; Yang D; Bao J; Li R; Xiao Y; Hou C; Wang H; Liu J; Yang D; Xu Y; Cao Z; Gao Z
    Crit Care; 2020 Jul; 24(1):422. PubMed ID: 32660650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection.
    Mezoh G; Crowther NJ
    Adv Exp Med Biol; 2021; 1321():33-43. PubMed ID: 33656711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease.
    Gan R; Rosoman NP; Henshaw DJE; Noble EP; Georgius P; Sommerfeld N
    Med Hypotheses; 2020 Nov; 144():110024. PubMed ID: 32758871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications.
    Iwasaki M; Saito J; Zhao H; Sakamoto A; Hirota K; Ma D
    Inflammation; 2021 Feb; 44(1):13-34. PubMed ID: 33029758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19.
    Bernard I; Limonta D; Mahal LK; Hobman TC
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33375371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
    D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
    World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection.
    Maiuolo J; Mollace R; Gliozzi M; Musolino V; Carresi C; Paone S; Scicchitano M; Macrì R; Nucera S; Bosco F; Scarano F; Zito MC; Ruga S; Tavernese A; Mollace V
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-Converting Enzyme 2 in the Pathogenesis of Renal Abnormalities Observed in COVID-19 Patients.
    Azinheira Nobrega Cruz N; Gonçalves de Oliveira LC; Tedesco Silva Junior H; Osmar Medina Pestana J; Casarini DE
    Front Physiol; 2021; 12():700220. PubMed ID: 34497535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis.
    Bhargavan B; Kanmogne GD
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19.
    Maruhashi T; Higashi Y
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
    Cheng H; Wang Y; Wang GQ
    J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality.
    Aleksova A; Fluca AL; Gagno G; Pierri A; Padoan L; Derin A; Moretti R; Noveska EA; Azzalini E; D'Errico S; Beltrami AP; Zumla A; Ippolito G; Sinagra G; Janjusevic M
    Life Sci; 2022 Dec; 310():121018. PubMed ID: 36183780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection.
    Labò N; Ohnuki H; Tosato G
    Cells; 2020 Jun; 9(7):. PubMed ID: 32629875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.